Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PQ-203 |
| Synonyms | |
| Therapy Description |
PQ-203 is a peptide-drug conjugate targeting SORT1, which potentially decreases growth of SORT1-expressing tumors (Clin Cancer Res (2025) 31 (12_Supplement): P4-12-17). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PQ-203 | PQ203|PQ 203 | PQ-203 is a peptide-drug conjugate targeting SORT1, which potentially decreases growth of SORT1-expressing tumors (Clin Cancer Res (2025) 31 (12_Supplement): P4-12-17). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07190469 | Phase I | PQ-203 | A Phase 1 Study of PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer | Recruiting | USA | CAN | 0 |